* GENOSCIENCE PHARMA *
2001 - Méditerranée
Marseille
www.genosciencepharma.com Discovery, Drugs
(also, Contract, Research)
Key words: Antivirals, Predict-Search, GenMol, Protease inhibitor, HCV
Mission: to develop new drugs for the treatment of viral diseases and the identification of molecular markers to monitor antiviral therapies and to answer the problem of microarray interpretation, by using PredictSearch, a proprietary powerful data mining based software
Clients: Pharmaceutical industry
namrani@3dgenoscience.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.: (interim) Halfon (Philippe) [founder, born 1960, M.D., Ph.D., Alphabio (CEO)]
Sc.Dir.: Benech (Philippe) [Ph.D., ex-CNRS]
Fin.Dir.:
BusDev:
Financers: | Turnover (M€) : 0.015 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Virus
Position : Preclin
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME | | 2006 .11 | Acquisition of Genosedi, a bio-informatics venture | ACQ+ | [5 years] |
| 2001 .08 | Company founded by Prof. Philippe Halfon | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
